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Increased 18F-fluorodeoxyglucose uptake in
abdominal aortic aneurysms in positron
emission/computed tomography is associated
with inflammation, aortic wall instability, and
acute symptoms
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Hans-Henning Eckstein, MD,a and Bernd-Joachim Krause, MD,b Munich, Germany
Objective:With the established computed tomographic (CT)-morphologic parameters, only the relative, but not the individual
rupture risk of abdominal aortic aneurysm (AAA), can be determined. So far, increased aortic 18F-fluorodeoxyglucose (FDG)
metabolismmeasured by positron emission tomography (PET) has been reported inAAAwith increased rupture risk. The aim
of the study was to analyze the histopathologic changes in AAA wall correlated with increased FDG uptake for further
implications on aortic wall stability and AAA rupture risk.
Methods: Fifteen patients with asymptomatic (n 12) and symptomatic (n 3) AAA underwent FDG-PET/CT, followed by
open AAA repair. FDG-PET/CT was used for precise localization of maximum FDG uptake, and the maximum standard
uptake values (SUVmax) were calculated. Biopsies of the AAA wall were operatively collected from areas with maximum FDG
uptake, immunohistologically stained, and semiquantitatively analyzed for inflammatory infiltrates, vascular smooth muscle
cells (VSMC), matrix metalloproteinase (MMP)-2 and -9 expression, as well as for elastin and collagenous fibers.
Results: Symptomatic AAA showed significantly increased FDG uptake compared with asymptomatic AAA (SUVmax, 3.5 
0.6 vs 7.5 3; P< .001). Thus, increased FDG uptake was correlated with higher densities of inflammatory infiltrates
(r  0.87, P < .01) and macrophage and T-cell infiltrations (r  0.95, P < .01 and r  0.66, P < .05), with
higher MMP-9 expressions (r  0.86; P < .01), and with reduction of collagen fiber (r  –0.76; P < .01) and
VSMCs (r  –0.71; P < .01). Consecutive correlations were found for total inflammatory infiltrates, T lymphocytes,
and macrophages with MMP-9 expression (r  0.79, 0.79 and 0.74; P < .01). Moreover, MMP-9 expression
was correlated with decreasing collagen fiber content (r  –0.53, P < .05) and VSMC density (r  –0.57, P < .05).
Conclusions: Maximum aortic FDG uptake correlated significantly with inflammation, followed by increased MMP
expression and histopathologic characteristics of aneurysm wall instability and clinical symptoms. Therefore, FDG-
PET/CTmight be a new diagnostic technique to study AAA disease in vivo and may contribute to improve prediction of
individual AAA rupture risk. ( J Vasc Surg 2008;48:417-24.)
Clinical Relevance: With the established CT morphologic parameters, the exact rupture risk of individual abdominal
aortic aneurysm (AAA) cannot be determined. Regarding AAA formation and rupture, metabolic processes that weaken
the aortic wall, such as chronic inflammation and proteolysis, have a pivotal role. This pilot study demonstrated that
increased metabolism in the AAA wall can be visualized by 18F-fluorodeoxyglucose (FDG) positron emission tomogra-
phy (PET)/computed tomography (CT). Furthermore, aortic FDG uptake correlated with inflammation, histopatho-
logic characteristics of aneurysm wall instability, and clinical symptoms. Therefore, after further investigation FDG-
PET/CT might be a new diagnostic technique to assess AAA wall stability in vivo and consequently may contribute to
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doi:10.1016/j.jvs.2008.03.059Rupture of abdominal aortic aneurysm (AAA) is fatal in
70% to 90% and is the 13th leading cause of death in
Western societies.1,2 As a consequence, precise prediction
of AAA rupture risk is essential. With the current, well-
established CT morphologic parameters, such as maxi-
mum aortic diameter, aneurysm shape, AAA expansion,
and computed wall stress, only the relative—but not the
individual rupture risk—can be determined.3 Hence,
AAA rupture may occur unexpectedly in aneurysms that
are smaller than the critical diameter limits, whereas
417
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patient’s lifetime, without prophylactic surgery.
In current pathologic concepts, metabolic processes
such as chronic inflammation and proteolysis play a pivotal role
inAAAformationandrupture.4-6With18F-fluorodeoxyglucose
(FDG) positron emission tomography (PET), increased me-
tabolism can be visualized in vivo and has been previously
described in aortic infection, arteritis, inflammatory AAA, and
casuistically in AAA with increased rupture risk (ie, symptom-
atic AAA).7,8 However, the histopathologic changes in AAA
wall associated with increased FDG uptake and their putative
impact on aortic wall stability still remain unclear.
In this pilot study we analyzed operatively retrieved sam-
ples from sites withmaximumFDGuptake in AAA vessel wall
in symptomatic and asymptomatic AAA accurately localized
by FDG-PET/CT. The intensity of FDG uptake was corre-
lated with semiquantitatively evaluated main determinants of
aortic wall integrity andmetabolism such as inflammatory cell
infiltration, matrix metalloproteinase (MMP)-2 and -9 activ-
ity, and elastin and collagen fiber content.
MATERIALS AND METHODS
Patients. The cohort comprised 15 patients (13 men,
2 women) with a mean age of 69  5 years (range, 61-77
years) with asymptomatic (n  12) and symptomatic (n 
3) AAA. These patients had specific abdominal pain and
underwent FDG-PET/CT, followed immediately by pro-
phylactic or urgent conventional open aneurysm repair.
Surgery was performed in isolated AAA in 13 and in thora-
coabdominal AA (TAAA) with infrarenal descending dis-
ease in two. In these two patients the region of interest was
limited to the abdominal part of the aorta. In addition, 24
age-matched control patients without aortic aneurysm dis-
ease were analyzed for aortic tracer uptake. Exclusion cri-
teria were chronic renal failure (serum creatinine 1.8
mg/dL), acute congestive heart failure, known intolerance
against CT- iodinated contrast media, or elevated blood
glucose level (130 mg/dL).
The study was conducted with the approval of our Insti-
tutional Review Board, and we obtained informed consent
from all the subjects before their participation in the study.
Protocol for FDG-PET/CT. Patients were instructed
to fast for at least 6 hours before the PET/CT examination.
After a bolus of 370 MBq was FDG injected into a periph-
eral vein (uptake time, 90 minutes) a low-dose CT scan
(Siemens Biograph Sensation 16, Erlangen, Germany; 120
kV, 20mAs) was obtained at first for attenuation correction
of PET emission data, followed by routine diagnostic native
and contrast-enhanced thoracoabdominal multi-slice CT
with intravenous injection of 100 mL contrast medium
(Imeron 300, Byk-Gulden, Konstanz, Germany; flow, 4
mL/s over the cubital vein; table speed, 12 mm/s, 5-mm-
slice thickness reconstruction). The data were processed on
a VolumeWizard workstation (Siemens Medical Solutions,
Erlangen, Germany), slices were indexed at 3 mm, and
three-dimensional multiplanar reconstructions of the aorta
and side branches were obtained. Immediately after the CT
scanning, PET emission images were acquired for 3 min-utes for each bed position. The emission data were consec-
utively reconstructed withmeasured attenuation correction
based on the low-dose CT transmission data.
Image analysis. All FDG-PET/CT scans were preop-
eratively visually analyzed by a nuclear medicine physician
and a vascular surgeon on a Syngo workstation (Siemens
Medical Solutions). The superimposed CT and PET images
were assessed for aneurysm morphology and distribution of
FDG tracer uptake. Areas with maximum focal FDG uptake
were visually detected, and the maximum standard uptake
value (SUVmax) in each aneurysm was obtained by computa-
tional analyses using the True D software (Siemens Medical
Solutions). These areas were mapped precisely for later intra-
operative identification. For mapping, distances to the renal
arteries and the aortic bifurcation were assessed, and the
localization in the cross-sectional plane was defined clockwise.
Tissue collection and immunohistochemistry. For
analyses of histopathologic changes at sites of maximum
focal intramural glucose metabolism, corresponding AAA
vessel wall specimens were operatively retrieved from all
patients during conventional AAA repair. Histologic speci-
mens were then dissected of luminal thrombus and peripheral
tissue, fixed in 4% paraformaldehyde, and embedded in paraf-
fin. Sections were routinely stained with hematoxylin-eosin
and elastin van Gieson to assess the overall tissue architecture,
infiltrates, elastin, and collagen. For immunohistochemistry,
paraffin sections were dewaxed in xylene and rehydrated
through graded ethanol (100% to 70%) to water.
Primary antibody solution was added for 1 hour at
room temperature. MMP-2 epitope was detected using
mouse monoclonal antibody (Ab-4, clone A-Gel VC2;
Lab Vision, Fremont, Calif) and MMP-9 by epitope-
specific rabbit antibody (Lab Vision). Colocalization
studies were done for macrophages (mouse monoclonal
anti-human CD68, clone KP1; DakoCytomation, Ham-
burg, Germany), vascular smooth muscle cells (VSMC,
antihuman smooth muscle actin [SMA], clone HHF3S;
DakoCytomation), endothelial cells (antihuman vonWillebrand
factor VIII, clone F8/86; DakoCytomation), and lymphocytes
(polyclonal rabbit antihumanCD3;DakoCytomation).After the
primary antibody incubation, visualization was performed using
ChemMateDetection Kit (LSAB, DakoCytomation) according
to themanufacturer’s instructions. All sectionswere evaluatedby
three experienced observers blinded to FDG-PET/CT results
and to each other.
According to the inhomogeneous and accentuated dis-
tribution of histopathologic patterns, semiquantitative
analyses were performed to describe the predominant his-
tologic characteristics in the entire sample. Specimens were
evaluated by using a score of 0 to 6, with 0 indicating no,
1 indicating weakly positive, 2 indicatingmore positive,
3 indicating intermediate positive, 4 indicating mark-
edly positive, 5 indicating strongly positive, and 6 indi-
cating massive positive staining.
Statistical analysis. For statistical analyses, the non-
parametric Kruskal-Wallis and Mann-Whitney test were
used to describe differences in subgroups because parame-
ters were not normally distributed. For correlation analyses,
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applied. Values of P  .05 were considered significant.
SUV values are shown as mean  standard deviation.
RESULTS
Patients. The study comprised 15 patients (13 men, 2
women) with a mean age of 69  5 years (range, 61-77
years). The AAAs were asymptomatic in 12 (11 men, 1
woman; mean age of 70 5 years; range, 61-77 years) and
symptomatic in three (2 men, 1 woman; mean age of 68
5 years; range, 64-74 years). Symptomatic patients pre-
sented with aneurysm-specific abdominal pain. Two pa-
tients had TAAAs and 13 had AAAs. The mean maximum
infrarenal cross-sectional aortic diameter was 59  12 mm
(range, 50-72 mm) in symptomatic patients and 54  8
mm (range, 45 for women to 72 mm) in asymptomatic
patients. History of aneurysm expansion could be assessed
reliably in seven patients. Of those, three AAAs were stable
with an annual growth rate 0.3 cm and 4 AAAs were
progressive (0.6 cm). No patient had an inflammatory or
mycotic AAA by intraoperative inspection during surgery.
Further patient characteristics for comorbidities and oral
medication are reported in the Table.
Tracer signal intensity vs clinical characteristics. In
the age-matched control group of 24 patients without
aortic aneurysm disease, the mean maximum infrarenal
aortic FDG uptake (SUVmax) was 3.0  0.5 (range, 2.4-
3.9). In comparison, the 12 asymptomatic AAA patients
showed significantly (P  .05) increased mean SUVmax
levels of 3.5 0.6 (range, 2.7-4.3). The three symptomatic
AAA patients had significantly higher focal FDG tracer
enhancement (mean SUVmax, 7.5  0.3; range, 4.8-9.1)
compared with asymptomatic AAA patients (P .001; Fig
Table. Demographic data
Variable
Symptomatic
AAA
Asymptomatic
AAA
Patient, No. 3 12
Age, mean  SD, years 68  5 68  5
Sex, F/M 1/2 1/11
Disease, AAA/TAA 2/1 1/11
Max diameter, mean  SD mm 59  11 54  8
Antiplatelet therapy, yes/no 2/1 11/1
NSAR, yes/no None 1/0
Statin, yes/no None 6/6
-Blocker, yes/no 1/2 7/5
Nicotine abuse, yes/no 2/1 10/2
Diabetes, yes/no 1/2 5/7
Arterial hypertension, yes/no 3/0 11/2
Coronary heart disease, yes/no 1/2 7/5
Renal insufficiency,a yes/no None 1/11
Elevated WBC (9.0 G/L)
yes/no 1/2 2/10
Elevated CRP (0.5 mg/dL)
yes/no 1/2 2/10
AAA, Abdominal aortic aneurysm; CRP, complement-reactive protein;
NSAR, nonsteroidal antirheumatics; TAA, thoracoabdominal aortic aneu-
rysm; WBC, white blood cell count.
aDefined as serum creatinine level 1.3 mg/dL.1 and Fig 2).History of AAA progression could reliably be ascer-
tained in seven of 15 patients. Three AAAs were stable
(annual AAA growth rate 0.3 cm), and four AAAs were
instable with rapid annual expansion of 0.6 cm; thus, no
significant correlation between maximum FDG uptake and
annual aneurysm growth rate was observed (P  .15).
Moreover, no association was found between SUVmax with
maximum cross-sectional infrarenal AAA diameter in the
15 symptomatic or asymptomatic patients.
Tracer signal intensity vs histopathologic character-
istics. In addition to the clinical course, the preoperatively
obtained SUVmax values were compared with correspond-
ing histologic specimens taken from areas with maximum
focal FDG uptake in the aneurysm vessel wall. Aneurysm
wall biopsy specimens were stained and semiquantitatively
assessed for inflammatory infiltrates, MMP-2 and MMP-9
activities, and collagen and elastin fiber content. No sex-
specific or age-dependent differences were found.
The total amount of inflammatory cells in the AAA
vessel wall was evaluated by conventional hematoxylin-
eosin staining. Furthermore, inflammatory cell subpopula-
tions were specified by CD3 (T-lymphocytes) and CD68
(macrophages) immunostaining. Thereby increasing SUVmax
levels were significantly associated with increasing medial
inflammatory cell infiltrates (r  0.87, P  .01). In-
creased SUVmax was significantly correlated with higher
densities of CD68-positive cells (macrophages, r0.95,
P .01) and with cells positive for CD3 (T lymphocytes, r
0.66, P .05; Fig 3 a, c, d and 4, A) Qualitatively, lower
FDG uptake was associated with macrophage and foam cell
accumulation adjacent to atheroma, whereas higher FDG
uptake was related to distinct medial inflammatory infil-
trates. Symptomatic AAA with SUVmax levels 5 showed
massive transmural CD68-positive cell infiltration (Fig 3, c)
Thereby histopathology showed typical characteristics of
chronic inflammation but no patterns indicating bacterial
infection. Similarly, histologic slides were assessed for
MMP-2 and MMP-9 expression and rated semiquantita-
tively. In correlation with the intensified FDG uptake, an
inconstant but significant increase of MMP-9 expression
was evident (r  0.86; P  .01). In two of three symp-
tomatic patients with the highest FDG uptake, surpassing
MMP-9 activity was obvious. In contrast, no significant
correlation was seen between FDG uptake and MMP-2
tissue staining (Fig 3, e, f and Fig 4, B).
Tracer signal intensity and AAA wall constituents.
Paired histologic slides of sites with maximum FDG uptake
were stained using elastin van Gieson and with antibodies
against -SMA. The slides were evaluated for elastic and
collagen fiber content and quality or VSMCs quantity. All
analyzed samples demonstrated characteristics of extensive
elastin and advanced collagen fiber degradation and disrup-
tion. Furthermore, aneurysm wall biopsy specimens showed
significant negative correlation of collagen fiber (r  –0.76;
P .01) and VSMC (r –0.71; P .01) content compared
with increasing SUVmax. Elastin quantity did not correlate
significantly with SUVmax (Fig 3, b and Fig 4,C); thus, all wall
specimens showed only low residual elastin fiber content.
effec
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addition to tracer signal intensity correlations with the
underlying histology, the correlation of inflammatory infil-
trates with MMP-expressions and AAA wall constituents
was also analyzed. Strong significant correlations were obvi-
ous for total inflammatory infiltrate, CD3 (T-lymphocytes),
Fig 1. An 18F-fluorodeoxyglucose (FDG) positron e
aortic aneurysm (AAA) vessel wall at maximum focal FD
(maximum diameter, 50 mm; maximum standard uptak
section; arrow, effusive aortic FDG uptake with spillover
Fig 2. Averagemaximum standard uptake values (SUVmax) of the
control group compared with patients with asymptomatic and
symptomatic abdominal aortic aneurysms (AAAs). Both, asymp-
tomatic and symptomatic patients showed significant increase in
uptake values compared with controls, with highest SUVmax levels
in the symptomatic AAAs.and CD68-positive cells (macrophages) with MMP-9 (r 0.79, 0.79, and 0.74; P  .01) but not for MMP-2.
Furthermore, significant negative correlation was found for
MMP-9 expression with collagen fiber content (r –0.53,
P  .05) and VSMC density (r  –0.57, P  .05). In
contrast, no significant correlation was seen between AAA
wall constituents and MMP-2 tissue expressions.
DISCUSSION
This pilot study analyzed the putative role of metabolic
imaging in AAA by FDG-PET/CT. The combined ana-
tomic and metabolic information of FDG-PET/CT imag-
ing allowed an exact localization of areas with maximum
FDG uptake in the aneurysm wall. In consequence, FDG-
PET/CT–guided intraoperative biopsy collection out of
these areas was enabled and for the first time in AAA, to our
knowledge, maximum tracer signal intensity could be com-
pared with the degree of histopathologic changes within
the aneurysm vessel wall.
In context with clinical presentation, the study demon-
strates that symptomatic AAA exhibited highly increased
FDG uptake compared with asymptomatic AAA and
healthy controls. Asymptomatic AAAs showed also signifi-
cantly increased maximum focal FDG uptake compared
n tomography/computed tomography of abdominal
take in a 66-year-old woman with a symptomatic AAA
ue, 9.1). Panel a, coronal section. Panel b, transversal
t.missio
G up
e valwith age-matched controls. This observation is in agreement
s. Ori
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tion and rupture as an active metabolic process4,5 with focal
accentuation.9 Interestingly, tracer uptake was indepen-
Fig 3. Histologic results to the corresponding 18F-flu
computed tomography from Fig 1. Panel a,Hematoxyli
Elastin von Gieson staining; arrows, collagen (red) and
antibody staining (brown); arrow designates CD68-po
antibody staining (brown); arrow designates CD3-positi
MMP-9 antibody staining (brown); arrow designates posit
arrow designates rarified smooth muscle actin–positive celldent from vessel diameter and AAA expansion. This obser-vation is partly in accordance with a previous report de-
scribing strong FDG signalling in PET for symptomatic
AAA but also in rapidly expanding AAA.8 This discrepancy
eoxyglucose uptake of positron emission tomography/
eosin staining; arrow, inflammatory infiltrates. Panel b,
tin (black) fibers in the tunica media; Panel c, CD68
cells with dens transmural infiltration; Panel d, CD3
ls; Panels e and f, Matrix metalloproteinase (MMP) -2,
lls); Panel g, Smooth muscle actin antibody staining (red);
ginal magnification, 50.orod
n and
elas
sitive
ve cel
ive cemay be explained by the small study population and the
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sodes of rapid expansion are followed by periods of stasis,10
with presumably lower detectable metabolic activity.
Furthermore, FDG-uptake signal intensity was corre-
lated with the underlying histopathology. Such semiquan-
titative correlation of FDG uptake with the degree of tissue
alterations has already been described for several inflamma-
tory diseases,11,12 but not so far in AAA. In general semi-
quantitative evaluation of histology seems imprecise, but
most of the aortic wall specimens showed inhomogeneous
and accentuated distribution of the main pathologic char-
acteristics. We therefore used semiquantitative visual eval-
uation to describe the predominant characteristic changes
in the entire specimen.
Our preliminary results demonstrated that low SUVmax
levels of asymptomatic AAA were correlated with macro-
phage infiltration adjacent to atherosclerotic lesions with low
density. In contrast, effusive FDG accumulation was strictly
Fig 4. Scatter plot of maximum standard values (SUVmax) of
fluorodeoxyglucose F18 uptake compared with (A) inflammatory
cell infiltrate, (B)matrix metalloproteinase (MMP)-2 and -9 activ-
ities, and (C) content of elastin, collagen, and vascular smooth
muscle cells (VSMC) in the corresponding area of abdominal
aortic aneurysm (AAA) vessel wall. Cell densities were semiquan-
titatively determined and scored from 0 to 6. Increasing SUVmax
correlated significantly with higher densities of (A) inflammatory
infiltrates and (B)MMP-2 orMMP-9.C,Negative correlation was
found for collagen and VSMCs but not for elastin.associated with massive transmural macrophage, T-cell infil-tration, and clinical symptoms. These results confirm previous
casuistic reports identifying macrophages as a main cellular
source of FDG glucose hypermetabolism in the aortic wall in
atherosclerosis and inflammatory vessel disease.13,14
Apart from VSMCs, inflammatory infiltrates such as
macrophages are the main sources of MMPs in AAAs, and
focal proteolytic MMP hyperactivity may lead to AAA
rupture at relatively low levels of intraluminal pressure.15
Especially, MMP-9 and MMP-2 were frequently associated
with aneurysm growth and rupture.16,17 In our experiments,
increasing FDG uptake was significantly correlated only with
MMP-9 expression and inflammatory reaction predominantly
in symptomatic AAAs, whereas MMP-2 activity was indepen-
dent of SUVmax. These results are in accordance with the
recent findings evincing an elevated MMP-9 level but not
MMP-2 expression at rupture sites of AAAs.9,18
Furthermore, reciprocal to the increased tracer activity,
a significant reduction of resident -SMA-positive mesen-
chymal cells was observed. Hence, VSMCs seem unlikely to
be responsible for relevant FDG turnover orMMP expression
in symptomatic AAAs. These results are consistent with his-
topathologic studies in AAAs that describe inflammatory in-
filtration accompanied by VSMC reduction with impaired
repair and maintenance of extracellular matrix proteins.19-20
The extracellular matrix proteins elastin and collagen, the
substrates of MMP proteolytic activity, are the main determi-
nants of aortic vessel wall stability. During the progression of
an AAA, the elastin content decreases whereas the collagen I
and III concentration increases,21,22 which is responsible for
most of the tensile wall strength.23 Consistent with these
observations, the ripe AAAs histologically analyzed in this
study revealed already an extensive degree of degradation and
reduction of elastin fibers, and the reduction of elastin fibers
was extensive and similar in all specimens. Therefore, no
significant correlation of elastin content with SUVmax could
be reached. In contrast, the collagen fiber content and quality
correlated negatively with increasing FDG uptake, in particu-
lar in symptomatic AAAs, indicating an area with minor AAA
wall strength prone to rupture.
The main limitation of this pilot study is the small study
population with undersized subgroups, in particular, of the
rare symptomatic patients. Consequently, statistical analyses
should be treated carefully. This study should demonstrate
only preliminary but encouraging results, the methodic ap-
proach, and clinical applicability of FDG-PET/CT in patients
with AAA. Moreover, to improve specificity of the FDG
signal, intraindividual correlation of histologic specimens
from areas with minimum and maximum FDG uptake
should be performed in future studies.
A further limitation is that the accuracy of FDG-
PET/CT imaging may be limited by the partial volume
effect observed in small or thin targets like aortic wall.
Furthermore, spillover of activity from the vessel lumen
may hamper exact quantification of the SUV in the vessel
wall (ie, accuracy of signal measurement could be influ-
enced by differences in either activity or volume). The
precision of the results can be further improved by partial
JOURNAL OF VASCULAR SURGERY
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for brain or lung imaging.24,25
CONCLUSION
FDG-PET/CT allowed a reliable preoperative localiza-
tion of areas with focally increased FDG uptake within the
aneurysm wall. Thereby, FDG accumulated in the vessel
wall of asymptomatic and symptomatic AAA. In symptom-
atic AAAs, FDG uptake values were significantly higher
compared with asymptomatic AAAs. Furthermore, we
found significant correlation of FDG signal intensity with
tissue inflammation. In addition, increased macrophage
and T-cell accumulation was correlated with increased
MMP-9 activity, followed by collagen degradation in areas
with intense focal FDG uptake, supporting the current
hypothesis that inflammatory changes are more pro-
nounced in symptomatic compared with asymptomatic
AAAs.4,5 The correlation of focal FDG uptake in PET/CT
with morphologic and biochemical changes assessed by
histology in the specimen in our study therefore provided a
more detailed insight in the pathophysiology of AAAs in
vivo. As a consequence, FDG-PET/CT imaging might be
a new approach to identify AAAs at risk before acute
aneurysm onset.
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